Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pretreatment lymphocyte-to-monocyte ratio as a predictor of survival among patients with ovarian cancer: a meta-analysis.

Gao XP, Liu YH, Liu ZY, Wang LJ, Jing CX, Zhu S, Zeng FF.

Cancer Manag Res. 2019 Feb 27;11:1907-1920. doi: 10.2147/CMAR.S184970. eCollection 2019.

2.

Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.

Lee SF, Ng TY, Spika D.

BMC Cancer. 2019 Apr 11;19(1):338. doi: 10.1186/s12885-019-5552-1.

3.

Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis.

Mao Y, Chen D, Duan S, Zhao Y, Wu C, Zhu F, Chen C, Chen Y.

Cancer Cell Int. 2018 Dec 6;18:201. doi: 10.1186/s12935-018-0698-5. eCollection 2018. Review.

4.

Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.

Li J, Cheng Y, Ji Z.

Medicine (Baltimore). 2019 Jan;98(2):e14091. doi: 10.1097/MD.0000000000014091.

5.

The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.

Guo YH, Sun HF, Zhang YB, Liao ZJ, Zhao L, Cui J, Wu T, Lu JR, Nan KJ, Wang SH.

Oncotarget. 2017 Mar 21;8(12):20011-20024. doi: 10.18632/oncotarget.15311.

6.

Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis.

Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS.

Onco Targets Ther. 2015 Dec 21;9:37-47. doi: 10.2147/OTT.S94458. eCollection 2016.

7.

Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.

Li W, Tao L, Zhang L, Xiu D.

Onco Targets Ther. 2017 Jul 11;10:3391-3397. doi: 10.2147/OTT.S142022. eCollection 2017. Review.

8.
9.

Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.

Li W, Ma G, Wu Q, Deng Y, Liu Y, Wang J.

Oncotarget. 2017 Aug 28;8(66):110606-110613. doi: 10.18632/oncotarget.20574. eCollection 2017 Dec 15.

10.

Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis.

Wu Q, Hu T, Zheng E, Deng X, Wang Z.

Medicine (Baltimore). 2017 Jun;96(22):e7051. doi: 10.1097/MD.0000000000007051. Review.

11.

Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports.

Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK.

Onco Targets Ther. 2016 May 20;9:3017-23. doi: 10.2147/OTT.S96910. eCollection 2016.

12.

The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.

Li M, Deng Q, Zhang L, He S, Rong J, Zheng F.

Pathol Res Pract. 2019 Jan;215(1):5-11. doi: 10.1016/j.prp.2018.10.026. Epub 2018 Oct 24. Review.

PMID:
30401580
13.

Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.

Ma JY, Liu Q.

Int J Surg. 2018 Feb;50:67-71. doi: 10.1016/j.ijsu.2018.01.002. Epub 2018 Jan 9. Review.

PMID:
29329786
14.

Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.

Huang LJ, Deng XF, Chang F, Wu XL, Wu Y, Diao QZ.

Medicine (Baltimore). 2018 Oct;97(43):e12858. doi: 10.1097/MD.0000000000012858. Review.

15.

Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis.

Hu RJ, Ma JY, Hu G.

Clin Chim Acta. 2018 Jun;481:142-146. doi: 10.1016/j.cca.2018.03.008. Epub 2018 Mar 12. Review.

PMID:
29544747
16.

[Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].

Niu JY, Zhu HY, Wang L, Fan L, Liang JH, Cao L, Wu W, Xia Y, Wu JZ, Li JY, Xu W.

Zhonghua Xue Ye Xue Za Zhi. 2018 Apr 14;39(4):265-270. doi: 10.3760/cma.j.issn.0253-2727.2018.04.001. Chinese.

PMID:
29779318
17.

Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis.

Zhang J, Chen L, Zhou R, Sun H, Liao Y, Liao W.

Gastroenterol Res Pract. 2016;2016:9801063. doi: 10.1155/2016/9801063. Epub 2016 Aug 9. Review.

18.

Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis.

Song W, Wang K, Zhang RJ, Zou SB.

Medicine (Baltimore). 2016 Dec;95(49):e5540.

19.

Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.

Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y.

Cancer Treat Rev. 2015 Dec;41(10):971-8. doi: 10.1016/j.ctrv.2015.10.003. Epub 2015 Oct 23. Review.

PMID:
26481060
20.

The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.

Tham T, Olson C, Khaymovich J, Herman SW, Costantino PD.

Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1663-1670. doi: 10.1007/s00405-018-4972-x. Epub 2018 Apr 13. Review.

PMID:
29651542

Supplemental Content

Support Center